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Over 60% of our severely combat-injured patient population develops radiographically apparent heterotopic os-
sification. Nearly a third of these require surgical excision of symptomatic lesions, a procedure that is fraughtwith
complications, and delays or regresses functional rehabilitation in many cases. Unfortunately, for the combat in-
jured,medical contraindications and logistical limitations limitwidespreaduse of conventionalmeans of primary
prophylaxis. Better means of risk stratification are needed to both mitigate the risk of current means of primary
prophylaxis as well as to evaluate novel preventive strategies currently in development. We asked whether
Raman spectral changes, measured ex vivo, correlatedwith histologic evidence of the earliest signs of HO forma-
tion using tissue biopsies from the wounds of combat casualties. In doing so, we compared normalmuscle tissue
to injuredmuscle tissue, unmineralized HO tissue, andmineralizedHO tissue. The Raman spectra of these tissues
demonstrate clear differences in the amide I and amide III spectral regions of HO tissue compared to normal
tissue, denoted by changes in the 1640/1445 cm−1(p b 0.01), and 1340/1270 cm−1 (p b 0.01) band area ratios
(BARs). Additionally, analysis of the bone mineral in HO by Raman spectroscopy appears capable of determining
bone maturity by measuring both the 945/960 cm−1 and the 1070/1445 cm−1 BARs. Raman may therefore
prove a useful, non-invasive, and early diagnostic modality to detect HO formation prior to it becoming evident
clinically or radiographically. This technique could ostensibly be utilized as a non-invasive means to risk stratify
individual wounds at a time thought to be amenable to various means of primary prophylaxis.
Published by Elsevier Inc.
Introduction
Heterotopic ossification (HO) is defined as the formation of mature
lamellar bone in soft tissues. Recently, our group has shown that the
prevalence of HO in combat-wounded service members approaches
65% [1,2]. Both the frequency and severity of this HO are far greater
than that observed following civilian trauma. Clinically, the impact of
this disease process can be devastating in some cases, and spans all
phases of treatment and rehabilitation. In fact, a recent analysis identi-
fied HO as the single most important barrier to functional mobility
and return to duty in active military amputees [3].
Conventional means of primary prophylaxis, such as external
beam radiotherapy (XRT) and non-steroidal anti-inflammatory drugs
(NSAIDS) exist, and, while they may be useful in some settings, they
are often impractical for combat casualties. For the combat casualty,
these options are logistically infeasible during the intercontinental aero-
medical evacuation process (XRT) and may be medically contraindi-
cated (NSAIDS) due to the high proportion of concomitant injuries
[4,5]. As such, thesemodalities cannot be recommended for widespread
use in all patients sustaining blast, or otherwise high-energy, combat
related injuries. Better means of early risk stratification and novel alter-
native means of prophylaxis are needed.
The typical combat wound requires a series of operative debride-
ment procedures due to severe contamination and slowly evolving
tissue declaration of viability. The debridements begin immediately
after injury and are generally continued three times per week until
definitive wound closure using local tissue, flaps or skin grafts can be
attempted [6]. General regions where HO will eventually form almost
always become clinically evident during the first three to four weeks.
Experienced surgeons have learned to recognize changes in the physical
properties of tissue that are indicative of HO, most notably a palpable
thickening and stiffening of tissues, which are evident during debride-
ment procedures. The physical effects of ossification of these tissues
can be felt when debridingwith a scalpel; however, oncemineralization
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occurs (usually weeks after injury), the process cannot be reversed, and
conventional means of primary prophylaxis are typically ineffective [7].
Furthermore, areas of mineralization are often ill-defined, and efforts
to preserve residual limb length and/or to provide durable muscular
coverage over fractures preclude excision of all tissues exhibiting early
signs of ectopic bone formation. Thus, in general, lesions continue to
develop until the ectopic bone is mature.
If wound-specific changes portending eventual HO formation could
be identified prior to the point at which lesions become palpable and/
or radiographically-apparent, prophylactic measures could be brought
to bear systemically or locally. Ideally, this process of detection and pro-
phylaxis should occur at a time early enough to influence osteoblastic
differentiation (the differentiation of progenitor cells into a bone-
specific lineage) and other requisite signaling processes necessary for
the development of HO. Similarly, if the exact location of the pre-HO tis-
sue could be more precisely defined, focused early debridement could
be performed, which may help prevent subsequent formation, and
also, theoretically, decrease the prevalence of symptomatic lesions.
Ramanvibrational spectroscopy is amodality that offers the capability
to accurately detect and identify various molecules that comprise the
wound environment in their native state. It is a spectroscopic technique
in which the precise biochemical composition of biologic samples can
be obtained via noninvasive and nondestructive means. Over the past
two decades, Raman spectroscopy has proven effective in assessing tis-
sues at the molecular level with diverse clinical and diagnostic applica-
tions to include the analysis of cellular structure and the determination
of tumor grade and type [8–12]. Accordingly, fundamental changes in
themolecular environment ofwounds that occur as a result of pathologic
alterations can be analyzed by vibrational spectroscopy [13–16]. These
identified changes can provide objective markers that correlate with
the various phases of wound healing, which can, with other clinical ob-
servations, be used to guide surgical decision-making. For instance, we
previously demonstrated that changes in collagen vibrational bands can
be correlatedwith alterations in collagen deposition associatedwith nor-
mal re-epithelialization of thewoundbed,while perturbations of the nor-
mal collagen ratios portended impaired or delayed wound healing [14].
Prior studies have also demonstrated the ability of Raman to effectively
identify and analyze bone and othermineralized tissues [17–20]. Because
clinical evidence and histological evidence point to mature HO tissue
closely resembling woven bone with a cortical shell, we postulate that
the Raman spectral profile of HO tissue resembles that of normal bone.
We ultimately seek to identify which wounds will develop HO as
early as possible— at a time thought to be amenable to primary prophy-
laxis. As such, the purpose of this proof of concept study was to deter-
mine whether Raman spectral changes, measured ex vivo, correlate
with histologic evidence of the earliest signs of HO formation using tissue
biopsies from the wounds of combat casualties.
Materials and methods
Clinical studies
The clinical studies were approved by the institutional review
boards of our institutions. Informed consent was obtained from all
study participants including those patientswhodonated untraumatized
muscle tissue that served as our control group. All injuredmuscle spec-
imens were obtained from U.S. service members evacuated following
high-energy combat-related extremity injuries sustained abroad. Even-
tual, radiographic, formation of HOwas subsequently confirmed at least
30 days post-injury for specimens in the injured/HO cohort.
Sample collection
“Normal” muscle samples (n = 10) were collected from excess,
discarded muscle tissue harvested during hamstring autograft prepara-
tion following routine, elective, anterior cruciate ligament reconstruction.
Injured muscle (n = 10) was collected from combat-injured patients
sustaining high-energy extremity injuries, during the initial debridement
upon arrival to our institution, prior to definitive wound closure or
coverage. All patients were treated with negative pressure wound thera-
py. Tissue biopsies, approximately 1 cm3, were obtained during surgical
procedures and immediately snap frozen. HO tissue biopsies were col-
lected during the surgical removal of symptomatic lesions from twenty
different injured patients and were subdivided into “early” (palpable,
but not radiographically apparent, n = 10) and “mature” (n = 10)
lesions. Additionally, “normal bone” control samples were collected
from transfemoral and ulnar amputations, an ACL reconstruction, and a
non-union fracture callus (n = 4). Samples were stored at −80 °C
until Raman spectroscopic analysis. Prior to Raman spectral acquisition,
sampleswere thawed in 0.9% NaCl saline solution. Sampleswere unfixed
at room temperature for no more than 15 min, to thaw the sample
and collect a Raman spectrum. After Raman spectral collection, the sam-
ple was immediately refrozen and stored at−70 °C. Prior to histopatho-
logical examination, all muscle and early HO tissue biopsies were
paraffin-embedded and stained with hematoxylin and eosin (H&E),
Masson's trichrome, and Alcian blue. Mature HO tissue was embedded
in glycolmethacrylate (GMA) and stained with H&E and von Kossa
stains. Stained tissue sections were examined for standard microscopic
evaluation.
Raman spectroscopy
Tissue samples were placed on an aluminum foil-covered weighing
dish prior to spectral acquisition. A 785 nm Raman PhAT system (Kaiser
Optical Systems, Inc., AnnArbor,MI)was used to collect spectra of the tis-
sue biopsies. Final spectra were the accumulation of forty 5-second spec-
tra, acquired using the 3 mm spot size. At least three dark-subtracted,
illumination-corrected spectra were obtained for each biopsy/sample.
All spectral preprocessing was performed in GRAMS/AI software
(Thermo Fisher Scientific, Madison, WI). Raman spectra were truncated
to 1800–400 cm−1 and baseline correctedwith a sixth degree polynomi-
al. Spectral subtraction of bloodwas performed if spectral interference of
blood was noted. All spectra were intensity normalized to the CH2 scis-
soring band at 1445 cm−1. Subsequently, curve fitting was performed
over three spectral regions, 1730–1500 cm−1, 1525–1185 cm−1, and
1150–900 cm−1. All Raman bands were fit with mixed Gaussian/
Lorentzian bands. Thefitwas considered goodwhen theR2 value reached
at least 0.99.
Band area ratios (BARs), a pseudoquantitative measure, were calcu-
lated by dividing the band area of a Raman band of interest (for example
1660 cm−1) by another band area (for example 1445 cm−1). Composi-
tional trends in related samples can be explored using BARs, such as an
increase in mineral carbonation (1070/960 cm−1) or a decrease in re-
ducible collagen crosslinks (1680/1660 cm−1); absolute Raman band
intensities and band areas can be greatly affected by optical effects
[18]. BARs calculated in this study include mineral carbonation (1070/
960 cm−1 and 1070/1445 cm−1), mineral maturity (945/960 cm−1),
protein order/disorder (1240/1270 cm−1), and α-helical structure
(1340/1270 cm−1). Mineral crystallinity is determined by the full
width at half maximum of the 960 cm−1 ν1 phosphate band.
Statistical analysis
Differences in band area ratios and band centers between groups
(normal muscle control, injured muscle, early HO, mature HO and nor-
mal bone) were assessed using independent-samples of Kruskal–Wallis
tests. Because four independent statistical tests were performed for
each parameter, a Bonferroni-adjusted significance level of 0.0125
was calculated to account for the increased possibility of type-I error.
Differences were considered statistically significant by a two-tailed
alpha ≤ 0.0125. Analyses were performed using SPSS software (SPSS
18.0, SPSS Inc., Chicago, IL).
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Results
Histopathologic characterization of tissue
Stained tissue sections of normal muscle and injured muscle
(Fig. 1) exhibit typical skeletal muscle histological attributes. Normal
myofibers are uniform while fibrous tissue infiltrates the injured
muscle myofibers. Heterotopic ossification is generally an intensely
vascularized lesion, appearing disorganized and hypercellular [21]. In
all HO specimens, lesion development begins adjacent to injured
muscle and is surrounded by fibrous connective tissue with long stand-
ing collagen fibrils. Towards the periphery of the lesion, trabeculae be-
come more clearly defined. Immature and mature HO osteoids (Figs. 2
and 3, respectively) contain large, immature osteocytes surrounded by
primitive woven bone. Unlike the immature HO tissue in Fig. 2, mature
HO tissue more closely resembles lamellar bone where cement lines
are obvious and bone marrow elements are prevalent throughout the
lesion. The presence of osteoclasts in themature HO, indicative of active
remodeling, is not evident; this is supported by the lack of scalloped
edges along the trabeculae, which appear smooth.
Raman spectroscopy of tissue biopsies
Raman spectroscopic examination was conducted for 44 ex vivo bi-
opsies collected from 44 patients, including control or “normal”muscle
(n = 10), injuredmuscle (n = 10), and HO tissue (n = 20). Addition-
ally, Raman spectra of collagen (types I, II and IV) were procured as
reference standards. The Raman spectral profiles of types I, II, and IV col-
lagen and normalmuscle (Fig. 4A), alongwith common Raman spectral
bands and their assignments for collagen, muscle and bone are
presented to highlight differences between their spectral profiles
(Table 1). Raman spectra of ex vivo samples of uninjured (or control)
muscle, injured muscle, and surgically excised heterotopic ossification
were also compared (Fig. 4B). Spectral differences are prominent in
the amide I, amide III, and fingerprint regions of the Raman spectra.
These changes reflect variation in the composition of the tissue itself,
both for the matrix and mineral components of tissue.
A more in depth characterization of both the matrix and mineral
components of tissue are presented in Figs. 5 and 6, respectively. Fig. 5
displays calculated band area ratios for the Raman spectra of control
muscle, injured muscle, early HO tissue, and mature HO tissue for
matrix bands. In general, when comparing muscle (normal or injured)
to HO tissue (early or mature), we noted a decrease in the 1660/
1445 cm−1 (p b 0.03), 1680/1445 cm−1 (p = 0.03), and 1340/
1270 cm−1 (α-helical structure, p b 0.01) band area ratios (BARs).
There is also an increase in the 1640/1445 cm−1 BAR (p b 0.01) and
the 1240/1270 cm−1 (protein order/disorder) BAR (p b 0.10). These
changes in BARs can also be examined as a progression of normal tissue
to diseased tissue.
Initially, after muscle injury, we observe an increase in 1660/
1445 cm−1, 1640/1445 cm−1, and protein order/disorder BARs. The
transition from injured muscle to early HO tissue demonstrates a de-
crease in the 1660/1445 cm−1 and α-helical structure BARs, and an in-
crease in the protein order/disorder BAR. Finally, the mineralization of
HO tissue shows a significant decrease in the α-helical structure BAR.
Fig. 6 comparesmineral band area ratios for normal bone and for HO
tissue. Both the 945/960 cm−1 band area ratio (mineral maturity) and
the 1070/1445 cm−1 band area ratio (mineral carbonation) provide a
A
EB
D
C
2 mm
200 µm
F
2 mm
200 µm
200 µm 200 µm
Fig. 1. Muscle histopathology. Normal muscle (A, B — H&E and C — Masson's trichrome) is compared to injured muscle (D, E — H&E and F — Masson's trichrome). Upon microscopic
examination, injured muscle myofibers are surrounded by fibrous connective tissue while normal muscle myofibers are relatively uniform. Closer examination demonstrates inflammation
(evidenced by lymphocytes), myofiber degradation, necrosis, and hemorrhage in injured muscle tissue.
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measure of mineral maturity; as bone matures, the 945/960 cm−1 BAR
decreases (p = 0.012) and the 1070/1445 cm−1 BAR increases (p =
0.011). Early HO tissue was surgically removed within 165 days post-
injury (mean value) while mature HO was excised on average of over
600 days post-injury; this is reflected in the Raman spectral band area
ratios. Early HO has the highest mineral maturity BARs (mean =
0.44 ± 0.10) and the lowest mineral carbonation BARs (mean =
0.18 ± 0.04). This trend is reversed for mature HO, where the mineral
maturity band area ratios are lower than early HO (mean = 0.24 ±
0.10) and the mineral carbonation band area ratios are higher than
early HO tissue (mean = 1.23 ± 0.52).
Discussion
Combat related HO formation is theorized to follow a common
sequence of events [22]. First, an induction signal must occur [22]
which, in our patient population, is the creation of a high-energy pene-
trating wound, usually from a blast. This leads to a pronounced and
prolonged systemic and local inflammatory response [23]. Second, a
population of progenitor cells, previously identified in our patients
[24], expands and is primed to undergo osteogenic differentiation in
an environment conducive to osteogenesis. Adipocytes play a key role
in creating this milieu conductive to osteogenesis by providing an envi-
ronment of low oxygen tension in the tissue [25]. Ossification then pro-
ceeds by either an endochondral bone formation (aswith fibrodysplasia
ossificans progressiva) or intramembraneous bone formation (as with
progressive osseous heteroplasia) or both (as with myositis ossificans
circumscripta) [26]. In the case of endochondral ossification, a hypoxic
environment is conducive to brown fat development [25] and chondro-
cyte differentiation from mesenchymal cells [27]. Newly differentiated
chondrocytes become hypertrophic and express factors that promote
vascular ingrowth to include vascular endothelial growth factor
(VEGF) [28]. Finally, the subsequent neoangiogenesis allows for the
matrix mineralization and eventual ossification.
In this preliminary study, we used Raman spectroscopy to discern
molecular changes that occur prior to and during the formation of HO.
2 mm
200 µm
200 µm
A
D
C
B
E
200 µm 
200 µm
200 µm
2 mm
F
G
200 µm
H
200 µm
Fig. 2. Osteoid histopathology. Immature (A–D) and mature osteoid (E–H) development of HO tissue is compared. Both tissue specimens were collected from a patient approximately
60 days post-injury. Sections are stained with H&E (A, B, E, F), Masson's trichrome (C & G), and von Kossa (D & H). Immature osteoid on H&E stained slides appears more eosinophilic
than mature bone (B) and only stains blue with Masson's trichrome (C). As the osteoid matures, Masson's trichrome reveals osteoid that stains both blue and red (G). Von Kossa staining
corroborates these results by demonstrating a greater degree of mineralization (darker stain) in the mature osteoid (D & H).
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Fig. 3.Mature HO histopathology. The figure displays stained tissue sections of mature HO tissue (H&E andMasson's trichrome— A & B and C & D, respectively). In this particular patient,
the HO developed directly adjacent to the femur, beneath a skin grafted area which had been treated with INTEGRA® bioartificial dermal replacement (Integra Life Sciences; Plainsboro,
NJ) application pre-skin graft. The HO lesion was excised over 160 days post-injury, after ulcerating and becoming persistently symptomatic.
Fig. 4. Representative Raman spectral profiles. A) Raman spectra of normal muscle ( ), type I collagen ( ), type II collagen ( ), and type IV collagen ( ). Obvious differences are
apparent in the amide I, the amide III envelope, and the C\C backbone stretching bands (denoted by the shaded boxes). The Raman spectrum of muscle contains an amide I band at
~1655 cm−1 while the collagen amide I band is shifted to ~1665 cm−1. Additionally, the amide III 1340 and 1320 cm−1 bands are much more prominent in the muscle spectrum but
the collagen spectra display increased amide III 1270 and 1245 cm−1 spectral bands. Finally, the 876 and 855 cm−1 Raman spectral bands of the collagen spectra are more intense
than those exhibited in themuscle spectrum. B) Raman spectra of normalmuscle ( ), early HO tissue ( ), andmature HO tissue ( ). Shaded boxes indicate regionswhere vibrational
bands differ significantly. The mean band center for the amide I band of uninjured muscle is 1655 cm−1. For the HO tissue, whether early or mature, the amide I band shifts to a higher
frequency and is centered at 1660 cm−1. Differences are also apparent in the amide III envelope of the spectra. The intensity of the 1340 cm−1 Raman vibrational band is decreased in the
spectra of the HO tissue compared to the uninjuredmuscle tissue. The 1270 cm−1 and 1240 cm−1 Raman vibrational bands are increased in the spectra of the HO tissue compared to the
uninjured muscle. The most notable difference in the spectrum of the mineralized HO tissue is the presence of the 960 cm−1 band, a ν1 P\O stretching mode. This is a typical Raman vi-
brational band observed for hydroxyapatite, and in this case, for the carbonated hydroxyapatite in bonemineral. Finally, the intensities of the 921 cm−1, 876 cm−1, and 855 cm−1 bands
are more intense in the spectra of the HO tissue than in the spectrum of the uninjured or injured muscle.
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We compared normal muscle tissue to injured muscle tissue, early HO
tissue, and mature HO tissue. While mature HO tissue is generally
apparent upon physical examination and/or radiologic examination,
immature and largely unmineralized HO tissue is not as clinically obvi-
ous. The Raman spectra of various tissues demonstrate that there are
clear differences in the amide I and amide III spectral regions of HO tis-
sue compared to normal muscle tissue, which may indicate whether or
not muscle tissue will develop HO. These differences include a signifi-
cant shift in the location of the amide I band and an increase in some
of the amide III bands.
As injured muscle transitions to mineralized tissue, significant
changes in many matrix bands (Fig. 4B) are apparent. First, there is a
shift in the amide I band in the Raman spectra from 1655 cm−1
to 1660 cm−1 — this is likely due to increased collagen content
(p b 0.01). Second, the bandwidth of amide I band increases, evidenced
by a decrease in the 1660/1445 cm−1 BAR, a decrease in the 1680/
1445 cm−1 BAR, and an increase in 1640/1445 cm−1 BAR (Fig. 5).
Bands at 1640 and 1660 cm−1 are assigned to α-helix protein second-
ary structure while the band at 1680 cm−1 is assigned to β-sheet
protein secondary structure [29–31]. Muscle is composed largely of
actin and myosin, both which are more alpha helical in structure than
collagen [32]. As collagen content increases and muscle myofibers de-
generate, the band center and width more closely resemble that of col-
lagen, specifically type I collagen. Additionally, an increase in the 1680/
1445 cm−1 could be attributed to increased collagen crosslinking [33].
Third, the intensity of amide III bands changes, most notably with an in-
crease in the protein order/disorder BAR and a decrease in theα-helical
structure BAR (Fig. 5). The Raman band at 1240 cm−1 is attributed to
more disordered protein structures, such as those containing a large
number of β-pleats or random coils, while the 1270 cm−1 Raman
band is assigned to more ordered protein structures, such as those
Table 1
Raman vibrational band assignments [29–31,34,49–53].
ν (cm−1) Band assignment Component
593 ν4 PO43− bending Hydroxyapatite
821 ν(CC) of backbone Collagen; muscle
856 ν(CC) of hydroxyproline ring Collagen; muscle
873 ν3 P\OH stretching Bone
876 ν(CC) of hydroxyproline ring Collagen; protein
921 ν(CC) of proline ring Collagen; protein
938 ν(CC) of protein backbone Collagen; muscle; protein
945–952 ν1 PO43− stretch Amorphous calcium phosphate
959 ν1 PO43− stretch Hydroxyapatite
1004 ν(CC) aromatic ring Phe; collagen; muscle
1032 ν3 PO43−; ν(CC) skeletal; C\O stretch Bone; collagen; muscle
1071 ν1(CO32−) Bone
1075 ν3 PO43− stretch Hydroxyapatite
1080 ν(CC) and ν(CN) skeletal Collagen; muscle
1159 ν(CC) and ν(CN) skeletal Carotenoid
1178 ν(CC) and ν(CN) skeletal Collagen; muscle
1244 δ(CH2) wagging; ν(CN) amide III
disordered/β-sheet
Collagen; muscle
1274 ν(CN) and δ(NH) amide III α-helix Collagen; muscle
1297 δ(CH2) twisting Collagen; muscle
1343 γ(CH2, CH3) wagging Collagen; muscle
1385 δ(CH3) symmetric Collagen
1448 δ(CH2) scissoring Collagen; muscle
1524 Carotenoid Collagen; muscle
1552 ν(CC) ring stretch Collagen; muscle; Trp
1665 ν(CO) amide I Collagen; muscle
Fig. 5. Comparison of Raman vibrational band area ratios for matrix components of tissue. Statistically significant differences (p b 0.0125) are indicated by an asterisk (*).
Fig. 6. Comparison of Ramanvibrational band area ratios formineral components of tissue.
Statistically significant differences (p b 0.0125) are indicated by an asterisk (*).
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containing a large number of helical coils [34,35]. In fact, Raman bands
below 1270 cm−1 are very weak in protein with a large proportion of
helical structure and the absence of a Raman band at 1240 cm−1 is in-
dicative of helical structure [34], such as myosin in muscle.
The Raman spectrum of unmineralized HO tissue closely resembles
the Raman spectrum of type I collagen. Type I collagen plays an impor-
tant role not only in the process ofwoundhealing, but also in the forma-
tion of osseous tissue, such as HO. Osteoblasts secrete and deposit type I
collagen, which comprises 90% of bone matrix prior to mineralization
[36]. In some cases, the collagen that serves as an initiator of wound
healing may also act as the scaffold for the deposition of bone mineral.
Raman spectroscopy also provides insight into the actualmineraliza-
tion of the soft tissue. When symptoms persist and cannot be mitigated
via conservative modalities, HO is typically removed after surgeons are
confident that the HO has fully matured. This, in theory, decreases the
likelihood of local recurrence. Historically, scintigraphy in addition to
serum alkaline phosphatase has been used to confirm maturity of le-
sions [37–39], which was thought to occur approximately one year
from injury. We have, however, observed combat-related lesions to be
mature at approximately sixmonths post-injury, when cortical margins
appearwell-defined and remain unchanged on serial radiographs taken
at least onemonth apart. Raman spectroscopy can evaluate thematurity
of lesions directly [18]. The 960 cm−1 ν1 phosphate band in the Raman
spectrum of bone can be deconvoluted intomore than one Raman spec-
tral band, depending on the species of mineral present in the tissue. For
instance, the presence of a shoulder at 945 cm−1 has been attributed
to an amorphous calcium phosphate [40,41], thought to be a precursor
to mature bone's carbonated hydroxyapatite. As bone matures, this
shoulder will decrease; thus, the 945/960 cm−1 BAR can be used as a
measure of mineral maturity. This is evidenced by early HO in Fig. 6,
in which the least mature HO, had the highest 945/960 cm−1 BAR (cor-
responding histology shown in Fig. 2). Furthermore, the 1070 cm−1
Raman spectral band is attributed to a ν1 carbonate vibration. As bone
matures, the incorporation of carbonate into the mineral lattice in-
creases. Increased carbonate content has been associatedwith increased
crystallinity of bonemineral and bonematurity; thus, as increase in the
1070/1445 cm−1 BAR is indicative of increasedmineralmaturity. Again,
early HO has the lowest mineral carbonation BAR and histologically,
exhibits the least mature HO. The relationship between the mineral
maturity BAR and maturity is further illustrated by comparing early
HO to the mineral carbonation BAR of both mature HO and normal,
mature, lamellar bone (histology not shown). These band area ratios
have been correlatedwith bonemechanical properties such asmodulus,
yield stress, and fracture stress [20,42–47].
Based on these results, Raman spectroscopy may be useful to identi-
fy early wound specific changes that portend eventual HO formation.
As an intraoperative modality, Raman spectroscopy may have distinct
advantages over other techniques of assessing tissue during surgery
such as histology or inspection by the surgeon. Though, not widely
used, frozen section and/or permanent pathologic analysis can be used
to identify early stages associated with eventual HO formation. This
technique requiresmultiple wound biopsies, is time and labor intensive
and may not be sufficiently precise with regard to overall HO precursor
location and potential severity to guide surgical decision-making. Also,
the ability of a surgeon to identify early HO tissue during a debridement
is subjective and relies heavily on personal experience. Conversely, the
Raman technique described above could be adapted as an objective,
intraoperative, non-invasive means by which to risk stratify wounds,
without significant preparation or bias on the part of the interpreter. If
Raman spectroscopy demonstrates that a wound has Raman spectral
features associated with the formation of HO, prophylaxis could be
employed in select cases. Alternatively, in areas that appear prone to
HO development, which can be mapped with vibrational spectroscopy
more precisely than gross clinical assessment, the clinician can consider
early preferential excision of pre-HO tissue while the patient is under-
going debridement and/or amputation revision for final closure.
Additionally, Ramanmay also be useful for monitoring the develop-
ment and progression of HO non-invasively and without radiation. For
example, tomography techniques currently in development are able to
model bone mineral density in three-dimensional space [48]. With
such a model, the clinician may also be able to visualize areas of HO
formation as well as monitor the maturation of each portion of the
lesion(s), over time.
Conclusions
Though the number of samples examined herein was small and our
findings preliminary, the results are encouraging and certainly deserv-
ing of further study. Furthermore, all data acquisition and analysis in
this study were performed ex vivo and outside of the surgical suite.
Nevertheless, these results suggest that Raman spectroscopy correlates
with histologic appearance of tissues within combat wounds, and can
identify the earliest forms of mineralization in patients who are actively
forming HO. We believe it is possible to optimize existing Raman
spectroscopic equipment, such as fiber-probe coupled systems, for use
in the operating room during surgical debridements. This could provide
treating surgeons and researchers with an accurate, non-invasive
means by which to risk stratify individual wounds to receive systemic
and local means of primary prophylaxis currently in development.
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